Atlas Trials

Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer

Clinical trial NCT03373708 · UNKNOWN

Trial details

NCT number
NCT03373708
Sponsor
Zhiyong Yu
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Breast CancerChemotherapyEndocrine Breast Diseases
Start date
2017-12-20
Primary completion
2019-12-20
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.